Dr. Monty Pal on Leading Options for First Line Treatment of Advanced Kidney Cancer
Treating Newly Diagnosed Kidney Cancer
Will Combining Immunotherapies Better Fight Kidney Cancer?
The Right Time for Cancer Immunotherapy: Before or After Surgery?
Immunotherapy for Kidney Cancer Patients in the Front-line Setting: Coming Soon?
Improved Survival in Malignant Pleural Mesothelioma with Avastin Added to Chemotherapy
Should Avastin be Added to EGFR TKI Therapy for EGFR Mutation-Positive NSCLC?
ECOG 1505 Study: No Benefit of Post-Operative Avastin in Early Stage Lung Cancer Patients
Is the Survival Benefit with Avastin Added to Chemotherapy Enough to Change the Standard of Care in Mesothelioma?
Maintenance Therapy for Advanced NSCLC
What is the Role of Bevacizumab in Stage IV NSCLC?
Histology-Specific Regimens - Squamous
Discover more
Search
